Yale Medicine Magazine
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Scientists Honored for Research Unveiling Molecular Machines the Month of May Brought the Good Prestigious Honors in Science
june 2012 volume 8, issue 3 Advancing Biomedical Science, Education, and Health Care Scientists honored for research unveiling molecular machines The month of May brought the good prestigious honors in science. On the Campylobacter, which together cause chains of amino acids are formed into news that two School of Medicine 29th, Arthur L. Horwich, m.d., was most of the world’s food-borne illness. three-dimensional, functional struc- scientists, each of whom have done named a winner of the Shaw Prize Galán’s group has thoroughly tures. Misfolded proteins have been pathbreaking work on molecular ma- in Life Science and Medicine, along characterized the Salmonella “needle implicated in many diseases, including chines involved in human disease, had with his longtime scientific col- complex,” a syringe-like organelle Alzheimer’s disease and amyotrophic received high honors for their research. laborator Franz-Ulrich Hartl, m.d., through which the bacterium injects lateral sclerosis (als). On May 1 Jorge E. Galán, ph.d., dr.med., of the Max Planck Institute bacterial proteins into host cells during In 1989, Horwich’s lab, in collabo- d.v.m., chair and Lucille P. Markey of Biochemistry in Germany. infection, modulating the function ration with Hartl and his postdoctoral Professor of Microbial Pathogenesis Galán is renowned for his research of those cells for its own advantage. mentor Walter Neupert m.d., ph.d., and professor of cell biology, was elect- on the cell biology, biochemistry, im- In 2004, Galán and colleagues used discovered a specialized protein in yeast ed a member of the National Academy munobiology, and structural biology of cryoelectron microscopy to visualize called Hsp60 that acts as a protein- of Sciences (nas), one of the most the bacterial pathogens Salmonella and the three-dimensional structure of the folding machine. -
EMBO Conference Takes to the Sea Life Sciences in Portugal
SUMMER 2013 ISSUE 24 encounters page 3 page 7 Life sciences in Portugal The limits of privacy page 8 EMBO Conference takes to the sea EDITORIAL Maria Leptin, Director of EMBO, INTERVIEW EMBO Associate Member Tom SPOTLIGHT Read about how the EMBO discusses the San Francisco Declaration Cech shares his views on science in Europe and Courses & Workshops Programme funds on Research Assessment and some of the describes some recent productive collisions. meetings for life scientists in Europe. concerns about Journal Impact Factors. PAGE 2 PAGE 5 PAGE 9 www.embo.org COMMENTARY INSIDE SCIENTIFIC PUBLISHING panels have to evaluate more than a hundred The San Francisco Declaration on applicants to establish a short list for in-depth assessment, they cannot be expected to form their views by reading the original publications Research Assessment of all of the applicants. I believe that the quality of the journal in More than 7000 scientists and 250 science organizations have by now put which research is published can, in principle, their names to a joint statement called the San Francisco Declaration on be used for assessment because it reflects how the expert community who is most competent Research Assessment (DORA; am.ascb.org/dora). The declaration calls to judge it views the science. There has always on the world’s scientific community to avoid misusing the Journal Impact been a prestige factor associated with the publi- Factor in evaluating research for funding, hiring, promotion, or institutional cation of papers in certain journals even before the impact factor existed. This prestige is in many effectiveness. -
Program Project Grant
OMB No 0925-0001 and 0925-0002 (Rev 10/15 Approved Through 10/31/2018) __________________________________________________________________________________ BIOGRAPHICAL SKETCH NAME POSITION TITLE Associate Dean for Research and Graduate Marcia F. McInerney___________________ Studies (protected time for research) Distinguished University Professor eRA commons user name Medicinal and Biological Chemistry mmciner College of Pharmacy and Pharmaceutical Sciences University of Toledo EDUCATION/TRAINING INSTITUTION AND LOCATION YEAR(s) FIELD OF DEGREE STUDY University of Michigan Ph.D. 1989 Microbiology & Immunology Yale University School of Med. Postdoc 1989-1991 Immunobiology- Dr. Charles A Janeway Jr, Mentor Joslin Diabetes Center/Harvard School of Visiting Prof 1998-1999 Diabetes/ Medicine of Medicine/ Endocrinology Iacocca Fellow University of Michigan Visiting Prof 2008 Metabolism, of Internal Endocrinology, Medicine and Diabetes A. Personal Statement I have been involved for over 25 years in research on the autoimmune aspects of type 1 diabetes (T1D) and inflammation in type 2 diabetes (T2D). While in the Janeway Laboratory for my postdoctoral we were the first lab to show that islets in nonobese diabetic (NOD) mice did not express MHC class II molecules, but that expression of MHC class I increased significantly during the development of diabetes. Therefore, we established that beta cells were not presenting antigen to CD4 T cells (last publication listed). I have worked actively on autoimmunity in type 1 diabetes as evidenced by publications on autoantigens (insulin, glutamic acid decarboxylase), autoantibodies (anti-insulin receptor), T cells (CD8 and CD4), T cell clones and hybridomas (anti-insulin, antiGAD), humanized transgenic mice expressing the diabetes susceptibility DQ8 molecule that turned out to be an autoimmune model of human myocarditis, and the role of the insulin receptor in diabetes development which was supported by NIH. -
Download Your Copy Now
Boston Children’s Hospital and the Bold Ideas that Change the World 3 For the children, families, healers and scientists of Boston Children’s Hospital. Together, they break through the impossible to create healthier futures for all. Break Through: Boston Children’s Hospital and the Bold Ideas that Change the World Copyright © 2019 by Boston Children’s Hospital All rights reserved. No part of this book may be reproduced or transmitted in any form or by any means without written permission from the publisher. Editor and writer: Laurie Beckelman Designer: Mary Ann Guillette Contributing writer: Nicole Davis Published 2019 Second Edition 2019 Printed in Canada WITH GRATITUDE Generous donations from the following physician foundations, hospital departments and philanthropic funds fully supported publication of Break Through: Boston Children’s Hospital and the Bold Ideas that Change the World. Boston Children’s Heart Foundation Boston Children’s Hospital Department of Dentistry Boston Children’s Hospital Trust Boston Pediatric Neurosurgical Foundation Boston Plastic & Oral Surgery Foundation Children’s Hospital Department of Psychiatry Children’s Hospital Neurology Foundation Children’s Hospital Ophthalmology Foundation Children’s Hospital Pathology Foundation Children’s Hospital Pediatrics Associates Children’s Hospital Radiology Foundation Children’s Orthopaedic Surgery Foundation Children’s Sports Medicine Foundation Children’s Urological Foundation CHMC Anesthesia Foundation CHMC Cardiovascular Surgical Foundation CHMC Otolaryngologic Foundation -
1 Achieving a Fair and Effective COVID-19 Response: an Open
1 Achieving A Fair and Effective COVID-19 Response: An Open Letter to Vice-President Mike Pence, and Other Federal, State, and Local Leaders from Public Health and Legal Experts in the United States Sustained human-to-human transmission of the novel coronavirus in the United States (US) appears today inevitable. The extent and impact of the outbreak in the US is difficult to predict and will depend crucially on how policymakers and leaders react. It will depend particularly on whether there is adequate funding and support for the response; fair and effective management of surging health care demand; careful and evidence-based mitigation of public fear; and necessary support and resources for fair and effective infection control. A successful American response to the COVID-19 pandemic must protect the health and human rights of everyone in the US. One of the greatest challenges ahead is to make sure that the burdens of COVID-19, and our response measures, do not fall unfairly on people in society who are vulnerable because of their economic, social, or health status. We write as experts in public health, law, and human rights, with experience in previous pandemic responses, to set forth principles and practices that should guide the efforts against COVID-19 in the US. It is essential that all institutions, public and private, address the following critical concerns through new legislation, institutional policies, leadership and spending. ADEQUATE FUNDING AND SUPPORT FOR THE RESPONSE MUST BE PROVIDED ● Federal, state and local governments should act immediately to allocate funds to ensure that necessary measures can be carried out and that basic human needs continue to be met as the epidemic unfolds. -
In This Issue…
AAI Councillors Visit Capitol Hill, Extol Value of NIH Research See page 3 N FASEB Celebrates Its Centennial 12 AAI Looks Back—The 1918–1919 In This Issue… on Capitol Hill Influenza Pandemic 2 2012 AAI Election Results N NCATS Forms Industry Partnership 14 2012 AAI Annual Meeting Highlights N Does Your Degree Impact Your ™ 3 Focus on Public Affairs: 22 IMMUNOLOGY 2012 Sponsors NIH Funding Prospects? N AAI Holds Special Session on 24 Grant & Award Deadlines N New Dual Use Research Policy NIH Peer Review 28 Meetings Calendar N NIH Director Collins on TV N AAI Research Advocacy Program Engages 5 Key Partners 7 2012 AAI Advanced Immunology Cover Image: Course Program N FY 2013 NIH Funding Bill Clears Galacidalacidesoxiribunucleicacid Senate Committee 8 Members in the News See page 3 for details. 2012 AAI Election Results AAI congratulates the following members on their election to offices and committees for terms commencing July 1, 2012, and extends a sincere thanks to all candidates for their willingness to run and serve if elected. President (2012–2013) Nominating Committee The American Association Gail A. Bishop, Ph.D. (2012–2013) of Immunologists Carver College of Medicine Pamela S. Ohashi, Ph.D., F.R.S.C., Chair 9650 Rockville Pike Distinguished Professor of Microbiology Senior Scientist and Director Bethesda, MD 20814-3994 and Internal Medicine and Holden Immune Therapy Program Tel: 301-634-7178 Chair of Cancer Biology Ontario Cancer Institute Fax: 301-634-7887 University of Iowa Michael Croft, Ph.D. E-mail: [email protected] www.aai.org Vice-President (2012–2013) Professor and Head, Division of Marc K. -
2015/2016 IMP Research Report
RESEARCH REPORT 2015–2016 Cover: Connective tissue cells of axolotl finger. (see also p. 34) CONTENTS 02 Highlights 04 Introduction Jan-Michael Peters & Harald Isemann 06 Facts & Figures 8 Current Research 10 Meinrad Busslinger 12 Tim Clausen 14 Luisa Cochella 16 Wulf Haubensak 18 David Keays 20 Thomas Marlovits 22 Anna Obenauf 24 Andrea Pauli 26 Rushad Pavri 28 Jan-Michael Peters 30 Alexander Stark 32 Andrew Straw 34 Elly Tanaka 36 Alipasha Vaziri 38 Stefan Westermann 40 Manuel Zimmer 42 Johannes Zuber 44 What the group leaders say 46 In-house Services 48 BioOptics 49 Bioinformatics 50 Molecular Biology Service 51 Max Perutz Library 52 Mass Spectrometry and Protein Chemistry 53 Comparative Medicine and Transgenic Services 56 The IMP and the VBC 57 Scientific Advisory Board 58 Vienna Biocenter Core Facilities (VBCF) 60 Vienna Biocenter training programme 62 IMP seminar series 66 IMP’s awards and honours 68 Publications 74 Sponsors & partners 76 Imprint IMP RESEARCH REPORT 2015–2016 HIGHLIGHTS As of late 2016, the IMP has a new home. The move marks the grand finale in a series of highlights that the institute enjoyed in 2015/16. The scientific JANUARY Max-Birnstiel Lecture by the search committee for the milestones of the IMP 2015 James Allison of the MD Anderson first IMP Director in the 1980s. are often marked Cancer Center in Houston, Texas: Jeff Schatz passes away not long by publications, “Boosting the Immune System after the lecture, in October 2015. awards, grants and to Fight Cancer”. honours, or talks Max-Birnstiel Lecture by by distinguished MARCH Dignitaries from IMP, Ruslan Medzhitov, Professor of guest lecturers in our 2015 Boehringer Ingelheim, the city of Immunobiology at Yale School on-going seminar Vienna and others gather for of Medicine in New Haven, series. -
Else Kröner Fresenius Award 3
Zum 25. Todestag von Else Kröner Else Kröner Fresenius2013 Award 2 Else Kröner Fresenius Award 3 Liebe Leser, liebe Freunde und Partner der Else Kröner-Fresenius-Stiftung, mit Freude und Dankbarkeit geben wir Prof. Dr. Ruslan Medzhitov als Preisträger des Else Kröner Fresenius Awards bekannt. Seine For- schung wird unsere Vorstellungen von der Reaktion des Körpers auf Inhalt Infektionen neu definieren. 3 Editorial Ende 2011 beschloss die Else Kröner-Fresenius-Stiftung, zum 25. Todestag ihrer Stifterin ein außergewöhnliches Förderprojekt 4 Preisträger Ruslan Medzhitov: auszuloben: einen substanziellen, zukunftsgerichteten Forschungspreis Weit über die Immunologie hinaus auf einem der spannendsten Gebiete der medizinischen Forschung. Dieser Award soll nicht nur die Werte Else Kröners veranschaulichen, 11 Interview: Warum fühlen wir uns krank sondern auch die Bandbreite ihres Lebenswerks als Unternehmerin bei einem Infekt? und Stifterin. In Erfüllung von Else Kröners Wünschen richtet sich die Stiftungs- 14 Laudatio für Ruslan Medzhitov arbeit sowohl auf wissenschaftliche Inhalte als auch auf begabte junge Forscher. Ausschreibungen für Stipendien, Forschungspreise, Dokto- 16 Die Auswahl des Preisträgers randen- und Forschungskollegs – verschiedene Maßnahmen zielen da- rauf ab, engagierten Forschern Räume zu erschließen und Talente zur 17 Die Jury des Else Kröner Fresenius Awards Entfaltung zu bringen. Der Else Kröner Fresenius Award zeichnet herausragende Forschungs- In ihr Tagebuch schrieb die junge 20 Den Nachwuchs im Blick ergebnisse aus und fördert bedeutende Arbeiten in der Zukunft. Da- Pharmaziestudentin 1948, was zu bei entstehen auch Ausbildungsmöglichkeiten für junge Forscher. Wir einem Leitmotiv ihres Lebens wurde: 22 Sieben Rätsel der Immunologie möchten zeigen, dass in der medizinischen Forschung auch in jungen »Die Wissenschaft will erobert Jahren viel erreicht werden kann und dass die Wissenschaft attraktive sein.« Else Kröner erkannte schon 24 Grafik: Im Kampf gegen Infektionen Karrierewege bietet. -
A Young Scientist Scores Another First
july/august 2011 volume 7, issue 3 Advancing Biomedical Science, Education, and Health Care Couple’s passion for the arts inspires unique scholarship fund Having majored in philosophy and Association and a Jungian psychoana- to contributions from others, includ- history as an undergraduate at Trinity lyst and psychiatrist in private practice ing a matching gift from the School of College, in Hartford, Conn., David in San Francisco. Medicine to mark the school’s Bicen- Leof, m.d., a member of the School But Leof’s terror quickly evapo- tennial year. of Medicine’s Class of 1964, initially rated, and “as things unfolded, I was Another major influence on Leof found life at the medical school to be just like a little kid at Christmas,” he was Lippard’s successor as dean, “quite terrifying.” On his very first says. “I had an absolutely joyful time Frederick C. Redlich, m.d., a leg- day, then-Dean Vernon W. Lip- in medical school.” endary chair of the Department of pard, m.d., issued a sobering call to In gratitude, Leof and his wife, Psychiatry from 1950 to 1967 who responsibility, reminding the new Colleen, have made a bequest to the built the department into one of the students that medical school is only a School of Medicine of several million nation’s finest. It was Redlich, Leof brief chapter in the life of a physician. dollars, which will support medi- says, who encouraged him to go into Though the day would come when cal students who have distinguished psychiatry himself. After graduating, each student would receive a medical themselves in the arts or humani- Leof interned at Dartmouth College’s degree, “you have the rest of your life ties. -
SABRE Annual Report 2021
Sandler Asthma Basic REsearch Center University of California, San Francisco Progress Report Year 22 July 2021 Figure Legend: Multi-detector computed tomography (MCTD) lung scan of a patient with poorly controlled asthma revealed occlusive mucus plugs of varying size and shape, which has been shown to correlate with worse lung function (technique developed and refined in the Fahy SABRE Center lab with UCSF Radiology). Therapeutic dissolution of plugs remains a priority in the Fahy lab. (Image contributed by Brendan Huang). TABLE OF CONTENTS Mission Statement 2 Summary of Accomplishments Overview 3 Executive Committee: Members and Functions 24 Scientific Advisory Board Susan Kaech, Ph.D. 26 Mitchell Kronenberg, Ph.D. 27 Ruslan Medzhitov, Ph.D. 28 SABRE Center Investigators Richard Locksley, M.D. 30 Christopher Allen, Ph.D. 32 K. Mark Ansel, Ph.D. 34 Esteban Burchard, M.D., M.P.H. 36 John Fahy, M.D., M.Sc. 38 Jeoung-Sook Shin, Ph.D. 40 Prescott Woodruff, M.D., M.P.H. 42 SABRE Associate Investigators Mallar Bhattacharya, M.D., MSc. 45 Erin Gordon, M.D. 47 Andrew Schroeder, M.P.H. 49 Aparna Sundaram, M.D. 50 Core Facilities Microscopy/BIDC 53 Asthma Related Research Projects Primero Birth Cohort 60 Single Cell Sequencing in Nasal Polyp Patients 70 Contributions to Relevant Scientific Activities 74 Publications Supported by the Sandler Asthma Basic Research Center 79 Looking to the future 136 Biographical Sketches 138 Mission Statement The Sandler Asthma Basic Research Center (SABRE Center) is an investigative unit dedicated to basic research discovery in asthma. Founded in 1999, the SABRE Center is nucleated by basic scientists supported by advanced technology cores and linked with the greater scientific community through Center Grants and Program Projects focused around asthma research. -
Innovating Immunology: an Interview with Ruslan Medzhitov
A MODEL FOR LIFE Disease Models & Mechanisms 4, 430-432 (2011) doi:10.1242/dmm.008151 Innovating immunology: an interview with Ruslan Medzhitov Ruslan Medzhitov was inspired to become a researcher in immunology on reading a 1989 paper written by Charles Janeway that outlined a new theory for immune system activation. Just a few years later, having achieved a postdoc position in Janeway’s lab, he carried out the experiments that confirmed the theory, re-igniting interest in the field of innate immunity and launching his own career. Here, he discusses this early discovery and explains what he considers the three most important questions facing immunologists today. wo decades ago, the mechanisms Ruslan Medzhitov grew up in the former that led to the activation of the Soviet Union in a large city called Tashkent, adaptive immune system were where he enrolled in college at the age of 18. largely unknown. Adaptive Owing to unusual demographics at that time, immune cells – such as T and B the government extended its compulsory DMM cellsT – and the cytokines that they produce army service to college students for a short had been characterised in some detail, yet period, meaning that he had to spend two how an invading pathogen could induce their years serving in the Russian army before actions was a mystery. In 1989, Charles returning to complete his college education. Janeway proposed in a landmark paper (Janeway, 1989) how this might take place: How did your time in the army influence invariant molecular structures expressed by your academic training? invading pathogens would activate pattern Two years in the Russian army can be very recognition receptors on innate immune damaging – they were probably the most cells, which in turn would trigger the miserable two years of my life. -
Bridging Innate and Adaptive Immunity
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Leading Edge BenchMark Bridging Innate and Adaptive Immunity William E. Paul1,* 1Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892-1892, USA *Correspondence: [email protected] DOI 10.1016/j.cell.2011.11.036 The Nobel Prize in Physiology or Medicine for 2011 to Jules Hoffmann, Bruce Beutler, and the late Ralph Steinman recognizes accomplishments in understanding and unifying the two strands of immunology, the evolutionarily ancient innate immune response and modern adaptive immunity. Among the 15 Nobel prizes given for siveness. The celebration of immunolo- the eponymous complete Freund’s adju- discoveries in immunology, including the gists everywhere in response to this vant, consisting of killed Mycobacteria very first, the 2011 prize can be best well-deserved prize is tempered with tuberculosis organisms in a water-in-oil compared to the 1908 prize, shared by sadness, with Ralph Steinman having emulsion. two giants of modern science, Paul died on the Friday preceding the Monday Although this need to use adjuvants to Ehrlich and Ilya Metchnikoff. In awarding announcement of the award. obtain a robust immune response to that prize, the Nobel committee attemp- protein antigens was widely appreciated, ted to grapple with the divide that had Exploring Immunology’s ‘‘Dirty it was papered over as immunologists’ already arisen in the then infant